Thomas Heineman
Chief Tech/Sci/R&D Officer bei ONCOLYTICS BIOTECH INC.
Vermögen: 547 172 $ am 31.03.2024
Profil
Thomas C Heineman is currently the Chief Medical Officer at Oncolytics Biotech, Inc. He previously worked as the Senior Director-Clinical Research & Development at GSK Plc from 2006 to 2016.
He also held the position of Associate Professor at Saint Louis University School of Medicine.
From 2018 to 2020, he served as the Vice President & Head-Clinical Development at Halozyme Therapeutics, Inc. Additionally, he was the SVP & Head-Clinical Development at Denovo Biopharma LLC in 2020.
From 2016 to 2020, he worked as the Vice President & Head-Clinical Development at Genocea Biosciences, Inc. Dr. Heineman holds graduate and doctorate degrees from The University of Chicago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0,68% | 07.03.2024 | 516 200 ( 0,68% ) | 547 172 $ | 31.03.2024 |
Aktive Positionen von Thomas Heineman
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Chief Tech/Sci/R&D Officer | 01.08.2020 |
Ehemalige bekannte Positionen von Thomas Heineman
| Unternehmen | Position | Ende |
|---|---|---|
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.07.2020 |
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01.01.2020 |
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01.08.2016 |
| Saint Louis University School of Medicine | Corporate Officer/Principal | - |
Ausbildung von Thomas Heineman
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Health Technology |
